FDA Issues Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: PR Newswire
WALTHAM, Mass., March 13, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the U.S. to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19, and not for any other viruses or pathogens.The authorized test uses Applied Biosystems TaqPath Assay technology and is designed to provide patient results within four hours of a sample being received by a lab. The estimated time-to-result also includes time for sample preparation and instrument analysis."The authorization of our diagnostic test for COVID-19 will help to protect patients and enable medical staff to respond swiftly to treat those who are ill and prevent the spread of infection," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Clinical Trial Supply and Logistics Market Size Expected to Reach USD 8.58 Bn by 2034 [Yahoo! Finance]Yahoo! Finance
- Mesenchymal Stem Cells (MSC) Market Set to Surpass USD 9.72 Billion by 2032 | The Role of Biopharma Collaborations in Accelerating Growth [Yahoo! Finance]Yahoo! Finance
- End Market Growth, New Acquisitions Drive Thermo Fisher's Shares [Yahoo! Finance]Yahoo! Finance
- Mass Spectrometry Market Projected to Surpass USD 11.25 Billion by 2032 at a 7.74% CAGR, Driven by Rising Demand in Pharmaceutical and Environmental Applications - SNS Insider [Yahoo! Finance]Yahoo! Finance
- Cell Freezing Media Market Size To Worth USD 333.29 Billion by 2032 | CAGR of 9.15% [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 10/23/24 - Beat
TMO
Sec Filings
- 11/12/24 - Form 4
- 11/8/24 - Form 144
- 11/8/24 - Form 4
- TMO's page on the SEC website